Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi’s Aubagio Wins Final Approval From U.K. Cost Agency NICE
Bloomberg
Wed, 01/22/14 - 08:34 am
Tags:
Sanofi, Aubagio, NICE, MS, multiple sclerosis
Sanofi's LixiLan Progresses
Yahoo/Zacks.com
Fri, 01/17/14 - 08:37 am
Tags:
Sanofi, LixiLan, insulin, Lantus, diabetes, Zealand Pharma, Lyxumia
BIO and Sanofi are pushing FDA to tweak drug shortage rule for vaccines
Fierce Vaccines
Thu, 01/16/14 - 08:16 am
Tags:
Sanofi, FDA, flu vaccines, vaccines
The J.P. Morgan Healthcare Confab Monday Morning News Dump
TheStreet.com
Mon, 01/13/14 - 10:12 am
Tags:
JPMHC 2014, GSK, Intercept Pharma, Acorda Therapeutics, Cell Therapeutics, Novartis, Sanofi, Alnylam, Idenix, Alexion, Galena Biopharma, Incyte, Clovis Oncology, Dendreon, Merck, Arena Pharmaceuticals
Sanofi Pays $700 Million for Alnylam Drugs and Stake
Bloomberg
Mon, 01/13/14 - 08:47 am
Tags:
Sanofi, Alnylam, Patisiran
Johnson & Johnson And Medivation: A Prostate Cancer Marketshare
Seeking Alpha
Tue, 01/7/14 - 12:51 pm
Tags:
JNJ, Medivation, prostatce cancer, Astellas, Dendreon, Sanofi, Zytiga, Xtandi, Provenge
Sanofi is allowing open access from Jan. 1 on out
Fierce Pharma
Fri, 01/3/14 - 12:02 pm
Tags:
Sanofi, clinical trial data
Sanofi Will Share Clinical Trial Data, But There Is A Caveat
Forbes
Thu, 01/2/14 - 11:43 am
Tags:
Sanofi, clinical trial data
Grading Pharma In 2013: 16 Drug Companies Ranked
Forbes
Tue, 12/31/13 - 10:17 am
Tags:
Bristol-Myers Squibb, Celgene, Gilead Sciences, Biogen Idec, AbbVie, Roche, JNJ, GSK, Amgen, Novo Nordisk, Pfizer, Novartis, Merck, Sanofi, AstraZeneca, Eli Lilly
A Hard Lesson from Sanofi
WSJ Online
Mon, 12/30/13 - 05:48 pm
Tags:
Sanofi, Genzyme, Lemtrada, FDA, MS, multiple sclerosis
Sanofi MS Drug Lemtrada Fails to Win Backing of U.S. FDA
Bloomberg
Mon, 12/30/13 - 11:16 am
Tags:
Sanofi, Lemtrada, FDA, MS, multiple sclerosis
Big Pharma Stocks: Year in Review
Yahoo/TheStreet.com
Tue, 12/24/13 - 09:50 am
Tags:
Big Pharma, drug stocks, Merck, JNJ, GSK, Eli Lilly, Pfizer, Sanofi, Bristol-Myers Squibb
Sanofi faces U.S. class action over MS drug Lemtrada
Reuters
Fri, 12/20/13 - 11:58 am
Tags:
Sanofi, MS, multiple sclerosis, Lemtrada
Sanofi to tap ACC registry for cardiovascular clinical trial
Yahoo/Reuters
Thu, 12/19/13 - 08:09 am
Tags:
Sanofi, clinical trials, alirocumab, American College of Cardiology
Sanofi signs on to sell Vivus ED drug in emerging markets
Fierce Pharma
Fri, 12/13/13 - 04:52 pm
Tags:
Vivus, erectile dysfunction, Sanofi, Stendra, Qsymia
Keep an Eye on AstraZeneca, Avanir, Bristol-Myers Squibb and VIVUS Today
Motley Fool
Thu, 12/12/13 - 11:12 am
Tags:
AstraZeneca, Avair, Bristol-Myers Squibb, Vivus, metreleptin, Nuedexta, Avanafil, Sanofi
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wed, 12/4/13 - 11:38 am
Tags:
Bristol-Myers Squibb, GSK, JNJ, Ophthotech, Novartis, Regeneron, Roche, Sanofi
Does Sanofi Need to Turn to M&A to Bulk Up Its Oncology Assets?
Motley Fool
Tue, 12/3/13 - 11:35 am
Tags:
M&A, Sanofi, oncology, Celgene, Clovis Oncology, Seattle Genetics
PSivida: Undervalued Ophthalmology Small-Cap Investment With Upcoming Catalyst
Seeking Alpha
Tue, 12/3/13 - 11:04 am
Tags:
pSivida, ophthalmology, GSK, Novartis, Pfizer, Regeneron, Roche, Sanofi, Iluvien, Durasert, Medidur
Sanofi Announces New Phase 3 Results for Investigational New Insulin U300
Yahoo
Tue, 12/3/13 - 09:33 am
Tags:
Sanofi, insulin, diabetes, U300

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.